SC 13G

 

 

Securities and Exchange Commission

Washington, D.C. 20549

 

 

Schedule 13G

(Rule 13d-102)

Information to be Included in Statements Filed Pursuant

to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

Pursuant to § 240.13d-2

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No.     )*

 

 

Arteris, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

04302A104

(CUSIP Number)

December 31, 2021

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 04302A104    Schedule 13G    Page 2 of 8

 

  1    

  Names of Reporting Persons

 

  Bayview Legacy, LLC (formerly Arteris IP, LLC)

  2  

  Check the Appropriate Box if a Member of a Group

 

  (a)  ☐        (b)  ☐

 

  3  

  SEC Use Only

 

  4  

  Citizenship or Place of Organization

 

  Delaware

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

   5    

  Sole Voting Power

 

  0

   6  

  Shared Voting Power

 

  10,335,891

   7  

  Sole Dispositive Power

 

  0

   8  

  Shared Dispositive Power

 

  10,335,891

  9    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  10,335,891

10  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11  

  Percent of Class Represented by Amount in Row 9

 

  33.1%

12  

  Type of Reporting Person

 

  OO


CUSIP No. 04302A104    Schedule 13G    Page 3 of 8

 

  1    

  Names of Reporting Persons

 

  K. Charles Janac

  2  

  Check the Appropriate Box if a Member of a Group

 

  (a)  ☐        (b)  ☐

 

  3  

  SEC Use Only

 

  4  

  Citizenship or Place of Organization

 

  United States

Number of

Shares

 Beneficially 

Owned by

Each

Reporting

Person

With

   5    

  Sole Voting Power

 

  177,286

   6  

  Shared Voting Power

 

  10,335,891

   7  

  Sole Dispositive Power

 

  177,286

   8  

  Shared Dispositive Power

 

  10,335,891

  9    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  10,513,177

10  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11  

  Percent of Class Represented by Amount in Row 9

 

  33.6%

12  

  Type of Reporting Person

 

  IN


CUSIP No. 04302A104    Schedule 13G    Page 4 of 8

 

ITEM 1.

(a) Name of Issuer:

Arteris, Inc. (the “Issuer”).

 

  (b)

Address of Issuer’s Principal Executive Offices:

595 Millich Drive, Suite 200, Campbell, CA 95008

 

ITEM 2.

(a) Name of Person Filing:

Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:

Bayview Legacy, LLC (formerly Arteris IP, LLC)

K. Charles Janac

 

  (b)

Address or Principal Business Office:

The business address for each of Bayview Legacy, LLC and Mr. Janac is c/o Arteris, Inc., 595 Millich Drive, Suite 200, Campbell, California 95008.

 

  (c)

Citizenship of each Reporting Person is:

Bayview Legacy, LLC is organized under the laws of Delaware. Mr. Janac is a citizen of the United States.

 

  (d)

Title of Class of Securities:

Common Stock, par value $0.001 per share (“Common Stock”).

 

  (e)

CUSIP Number:

04302A104

ITEM 3.

Not applicable.


CUSIP No. 04302A104    Schedule 13G    Page 5 of 8

 

ITEM 4.

Ownership.

(a-c)

The ownership information presented below represents beneficial ownership of Common Stock of the Issuer as of December 31, 2021, based upon 31,254,895 shares of Common Stock outstanding as of November 26, 2021, based on the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on December 1, 2021.

 

Reporting Person   

Amount

beneficially

owned

    

Percent

of class:

    Sole
power
to vote or
to direct
the vote:
     Shared
power to
vote or to
direct the
vote:
    

Sole
power to
dispose or
to direct
the
disposition

of:

    

Shared

power to

dispose or

to direct

the

disposition

of:

 

Bayview Legacy, LLC

     10,335,891        33.1     0        10,335,891        0        10,335,891  

K. Charles Janac

     10,513,177        33.6     177,286        10,335,891        177,286        10,335,891  

Bayview Legacy, LLC is the record holder of 10,335,891 shares of Common Stock. Mr. Janac is the manager of Bayview Legacy, LLC and, as such, may be deemed to share beneficial ownership of the securities held of record by Bayview Legacy, LLC.

Mr. Janac may also be deemed to share beneficial ownership of 177,286 shares of Common Stock, which includes of (i) 100,000 shares of Common Stock held of record by Mr. Janac and (ii) 77,286 shares of Common Stock held of record by the Janac Trust.

 

ITEM 5.

Ownership of Five Percent or Less of a Class.

Not applicable.

 

ITEM 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

 

ITEM 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable.

 

ITEM 8.

Identification and Classification of Members of the Group.

Not applicable.


CUSIP No. 04302A104    Schedule 13G    Page 6 of 8

 

ITEM 9.

Notice of Dissolution of Group.

Not applicable.

 

ITEM 10.

Certification.

Not applicable.


CUSIP No. 04302A104    Schedule 13G    Page 7 of 8

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 10, 2022

 

Bayview Legacy, LLC
By:  

/s/ K. Charles Janac

Name:   K. Charles Janac
Title:   Manager
K. Charles Janac

/s/ K. Charles Janac


CUSIP No. 04302A104    Schedule 13G    Page 8 of 8

 

LIST OF EXHIBITS

 

Exhibit No.

  

Description

99    Joint Filing Agreement.
EX-99

Exhibit 99

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13G. Each of them is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

IN WITNESS WHEREOF, the undersigned hereby execute this Joint Filing Agreement as of February 10, 2022.

 

Bayview Legacy, LLC
By:  

/s/ K. Charles Janac

Name:   K. Charles Janac
Title:   Manager
K. Charles Janac

/s/ K. Charles Janac